<DOC>
	<DOCNO>NCT01209208</DOCNO>
	<brief_summary>The purpose study determine whether budesonide mesalazine active treatment lymphocytic colitis .</brief_summary>
	<brief_title>Budesonide Versus Mesalazine Versus Placebo Lymphocytic Colitis</brief_title>
	<detailed_description />
	<mesh_term>Colitis</mesh_term>
	<mesh_term>Colitis , Lymphocytic</mesh_term>
	<mesh_term>Mesalamine</mesh_term>
	<mesh_term>Budesonide</mesh_term>
	<criteria>Signed informed consent Symptoms sign indication lymphocytic colitis Infectious diarrhoea , Diarrhoea result presence symptomatic organic disease ( ) gastrointestinal tract endoscopichistological finding Celiac disease Pregnancy breastfeeding , Participation clinical trial</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>90 Years</maximum_age>
	<verification_date>February 2017</verification_date>
</DOC>